Given the high prevalence of Ureaplasma urealyticum infections within the realm of sexually transmitted infections (STIs), we leverage our extensive proficiency in Ureaplasma urealyticum infection diagnostics to deliver customized IVD solutions and holistic assistance, streamlining your path from diagnostic research to commercialization.
Introduction to Ureaplasma Urealyticum Infection
Ureaplasma urealyticum is a bacterium that can inhabit the human genital tract and is known for its association with various genitourinary conditions. Initially discovered in 1954, Ureaplasma urealyticum can exist as a commensal organism in healthy individuals or as a pathogen causing symptomatic infections. Since some people are asymptomatic after infection, this further increases the difficulty of detection and management.
Fig. 1 Research on the mechanisms of Ureaplasma urealyticum infections. (Motomura, Kenichiro, et al., 2020)
Diagnostic Biomarkers for Ureaplasma Urealyticum Infection
Diagnosing Ureaplasma urealyticum infections can be challenging due to their often asymptomatic nature and lack of specific features. Conventional diagnostic approaches, such as culture-based methods, may face constraints like reduced sensitivity and prolonged processing times. Thus, the exploration of innovative diagnostic biomarkers shows potential for improving the effectiveness and precision of diagnosing Ureaplasma urealyticum infections.
DNA Biomarkers
The specific DNA sequence of Ureaplasma urealyticum serves as a diagnostic biomarker. PCR testing is utilized for sensitive and specific pathogen identification, facilitating early detection and timely interventions for Ureaplasma urealyticum.
Antibody Biomarkers
The specific antibodies produced by the immune system against Ureaplasma urealyticum can offer insights into infection and individual immune status. Antibody testing can supplement DNA-based tests, offering a comprehensive insight into the infection status.
IVD Kits for Ureaplasma Urealyticum Infection
In vitro diagnostic (IVD) kits are designed to detect specific biomarkers associated with Ureaplasma urealyticum infections, aiding in the effective identification of the pathogen and management of the infection. These IVD kits are user-friendly and possess rapid and accurate diagnostic capabilities, providing convenient diagnostic tools that facilitate on-site testing and decision-making.
| Kits |
Applications |
Detection Methods |
| Ureaplasma Urealyticum Nucleic Acid Detection Kit |
Detection and identification of Ureaplasma urealyticum DNA in samples. |
Real-time PCR |
| Ureaplasma Urealyticum IgM Antibody Detection Kit |
Qualitative and quantitative determination of Ureaplasma urealyticum IgM antibodies. |
ELISA |
| Ureaplasma Urealyticum IgG Antibody Detection Kit |
Detection of Ureaplasma urealyticum IgG antibodies in urethral and genital secretion samples. |
ELISA |
Our Services
As pioneers in the field of infectious disease diagnostics, we offer cutting-edge IVD solutions tailored for addressing the intricate diagnostic requirements of Ureaplasma urealyticum infections. Our proficiency lies in crafting specialized IVD reagents/kits and state-of-the-art diagnostic devices for Ureaplasma urealyticum infections, enhancing diagnostic automation and fostering effective disease management.
Additionally, we offer point-of-care testing (POCT) and companion diagnostic development services tailored for Ureaplasma urealyticum infections. These services enable the creation of portable and user-friendly IVD tools, aiding in swift detection and personalized therapeutics of Ureaplasma urealyticum infections.
If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
Reference
- Motomura, Kenichiro, et al. "Intra-amniotic infection with Ureaplasma parvum causes preterm birth and neonatal mortality that are prevented by treatment with clarithromycin." MBio 11.3 (2020): 10-1128.
All of our services and products are intended for preclinical research use
only and cannot be used to diagnose, treat or manage patients.
